Home » Stocks » PGEN

Precigen, Inc. (PGEN)

Stock Price: $6.55 USD -0.20 (-2.89%)
Updated Jun 16, 2021 10:26 AM EDT - Market open
Market Cap 1.44B
Revenue (ttm) 97.85M
Net Income (ttm) -131.84M
Shares Out 193.50M
EPS (ttm) -0.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 16
Last Price $6.55
Previous Close $6.74
Change ($) -0.20
Change (%) -2.89%
Day's Open 6.69
Day's Range 6.47 - 6.75
Day's Volume 190,782
52-Week Range 3.36 - 11.10

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Precigen Inc's (NASDAQ: PGEN) subsidiary Precigen ActoBio announced topline results from the Phase 1b/2a study evaluating AG019 ActoBiotics to treat recent-onset type 1 diabetes (T1D). Results were pres...

5 days ago - Benzinga

GERMANTOWN, Md., June 10, 2021 /PRNewswire/ -- Precigen ActoBio, an innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents and a wholly-owned subsidia...

5 days ago - PRNewsWire

GERMANTOWN, Md,, June 10, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pa...

5 days ago - PRNewsWire

Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 31.25% and 23.51%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

GERMANTOWN, Md., May 10, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pat...

1 month ago - PRNewsWire

Precigen, Inc. (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to immunotherapies to new, personalized therapeutics. Precigen, Inc. (NASDAQ...

2 months ago - Benzinga

GERMANTOWN, Md., March 30, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today ...

2 months ago - PRNewsWire

GERMANTOWN, Md., March 23, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today ...

2 months ago - PRNewsWire

GERMANTOWN, Md., March 18, 2021 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today ...

2 months ago - PRNewsWire

Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 31.25% and -16.13%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

GERMANTOWN, Md., March 1, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pa...

3 months ago - PRNewsWire

Precigen, Inc. (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

The next GME will be hard to find, but these three stocks could be solid candidates for a potential short squeeze. The post 3 Troll-able Stocks That Could Be the Next GME appeared first on InvestorPlace.

Other stocks mentioned: CLVS, NAKD
3 months ago - InvestorPlace

GERMANTOWN, Md., Feb. 4, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pat...

4 months ago - PRNewsWire

The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's k...

Other stocks mentioned: CLVS, DVAX, LCI, NAKD, OPK, SENS, TXMD ...
4 months ago - Benzinga

GERMANTOWN, Md., Jan. 26, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously announced underwritten public offering of common stock. Precigen sold 17,250,00...

4 months ago - PRNewsWire

GERMANTOWN, Md., Jan. 22, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering ...

4 months ago - PRNewsWire

GERMANTOWN, Md., Jan. 21, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) today announced it has commenced an underwritten public offering of shares of its common stock. In addition, Precigen intends...

4 months ago - PRNewsWire

GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pa...

5 months ago - PRNewsWire

GERMANTOWN, Md., Jan. 6, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pat...

5 months ago - PRNewsWire

GERMANTOWN, Md., Jan. 5, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pat...

5 months ago - PRNewsWire

GERMANTOWN, Md., Dec. 15, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pa...

6 months ago - PRNewsWire

GERMANTOWN, Md., Dec. 7, 2020 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today an...

6 months ago - PRNewsWire

NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Precigen, Inc. f/k/a Intrexon Corporation (“Pre...

Other stocks mentioned: XON
6 months ago - Business Wire

Los Angeles, California--(Newsfile Corp. - December 4, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precigen, Inc. (...

6 months ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - December 4, 2020) -  Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securi...

6 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 3, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation (NASDAQ: PG...

Other stocks mentioned: XON
6 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - December 3, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precigen, Inc. ...

6 months ago - Newsfile Corp

NEW YORK, Dec. 3, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Precigen, Inc. f/k/a Intrexon Corporation ("Precigen" or the "Compan...

6 months ago - PRNewsWire

San Francisco, California--(Newsfile Corp. - December 2, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securit...

6 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 2, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Precigen, Inc. f/k/a Intrexon Corporati...

Other stocks mentioned: XON
6 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - December 2, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precigen, Inc. (...

6 months ago - Newsfile Corp

SAN FRANCISCO, Dec. 1, 2020 /PRNewswire/ -- Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securities fraud class actio...

6 months ago - PRNewsWire

San Francisco, California--(Newsfile Corp. - November 30, 2020) -  Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A secur...

6 months ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $PGEN #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 4, 2020 deadline to file a lead plaintiff motion in the class action file...

6 months ago - Business Wire

Los Angeles, California--(Newsfile Corp. - November 30, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precigen, Inc. ...

6 months ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - November 29, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securi...

6 months ago - Newsfile Corp

SAN FRANCISCO, Nov. 28, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Precigen, Inc. (N ASDAQ : PGEN ) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securities fraud cla...

6 months ago - GlobeNewsWire

NEW YORK, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Precigen, Inc. f/k/a (NASDAQ: PGEN, XON...

Other stocks mentioned: XON
6 months ago - GlobeNewsWire

San Francisco, California--(Newsfile Corp. - November 27, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securi...

6 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - November 27, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Precigen, Inc. ...

6 months ago - Newsfile Corp

NEW YORK, Nov. 27, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class actio...

Other stocks mentioned: XON
6 months ago - PRNewsWire

NEW YORK--(BUSINESS WIRE)-- #Intrexon--Scott+Scott Attorneys at Law LLP Alerts Investors to December 4 Lead Plaintiff Deadline in Securities Class Actions Against Precigen, Inc. (PGEN)

6 months ago - Business Wire

San Francisco, California--(Newsfile Corp. - November 24, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securi...

6 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - November 23, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation (NASDAQ: P...

Other stocks mentioned: XON
6 months ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - November 17, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now. A securi...

6 months ago - Newsfile Corp

GERMANTOWN, Md., Nov. 16, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of pa...

7 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - November 13, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Precigen, Inc. f/k/a Intrexon Corporation (NASDAQ: P...

Other stocks mentioned: XON
7 months ago - Newsfile Corp

Shares of Precigen (NASDAQ:PGEN) were unchanged after the company reported Q3 results.

7 months ago - Benzinga

About PGEN

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic com... [Read more...]

Industry
Biotechnology
Founded
1998
CEO
Helen Sabzevari
Employees
423
Stock Exchange
NASDAQ
Ticker Symbol
PGEN
Full Company Profile

Financial Performance

In 2020, Precigen's revenue was $103.18 million, an increase of 13.73% compared to the previous year's $90.72 million. Losses were -$170.52 million, -47.10% less than in 2019.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Precigen stock is "Buy." The 12-month stock price forecast is 12.50, which is an increase of 90.99% from the latest price.

Price Target
$12.50
(90.99% upside)
Analyst Consensus: Buy